Carcinoembryonic Antigen (CEA)

Carcinoembryonic Antigen (CEA)

Monitors treatment of individuals diagnosed with cancer. Testing is usually required before treatment begins, then utilized to measure response to treatment and whether the cancer has progressed or recurred.



Subscribe for
Testing Updates


Receive Emails with latest testing updates

and more recent Covid-19 Testing News